Bio-Reference Laboratories
在场
Bio-Reference Laboratories 的所有者是 Opko Health.
是其中之一......
Opko Health 是一家在股票代码 OPK (US) 下上市的公司。
Opko Health 拥有 3家子公司，其中包括 Bio-Reference Laboratories、ModeX Therapeutics 和 Opko Renal。
他们在：
高管
查看带有其 8 名主要高管的组织结构图
Bio-Reference Laboratories 搜索最多的简介
- Craig Allen, President and Chief Executive Officer
- James Weisberger, Chief Medical Officer and Executive Vice Preside...
- Merve Ozkus, Senior Vice President and Chief Information Officer
创建提醒
跟踪 Bio-Reference Laboratories 的高管变动
健康
Opko Health 拥有 1,967 家竞争者，其中包括 Siemens Healthineers (德国)、IQVIA (美国(美洲)) 和 Nestlé Health Science (瑞士)。
Popular M&A news in 健康
- Radon Medical Imaging 已收购 Alpha Imaging (公布2024十一月20号).
- TowerBrook Capital Partners 已收购 R1 RCM (公布2024十一月19号).
- Kewaunee Scientific 已收购 Nu Aire (公布2024十一月6号).
健康 行业的其他推荐联系人
消息
Bio-Reference Laboratories 的最新新闻稿
- OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
- OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results
- ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
- Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
- OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
- Press Releases
- Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
- OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
- OPKO Health Announces $100 Million Share Repurchase Program
- OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
- View more press releases Close
通过电子邮件
